CytoSorbents Corporation (CTSO)

[fantomphan]

It was an unrealistic goal to think REMOVE would show statistically significant mortality improvement? You lost me. I'm taking your word for it that it won't. How does a salesman sell the device based on that? Coupled with a needed trial for FDA, short or not. If no FDA trial requirement was improbable, why was this dangled? If Q2 had been the $12-$15 most here thought (please don't argue this, everyone I communicate privately with expected this), then Chan's guidance saying Q3 will be good but not the highest would not be concerning. I ask what do we have to look to to move the stock and pull us outta this slow dive(?) The constant "We've never been better yadda yadda" isn't doing it, nor do I see that message working again short term. Nobody's buying g what we're selling. Throw in investors who quickly snapped up over $50 million in stock now worth $10 million+ less. They must want someone's scalp. And I ask this seriously. Somebody tell me why we need a CEO and separate president and the added salary bonus that brings with it? Why?